General Information of Disease (ID: DIST9FNK)

Disease Name Cerebrotendinous xanthomatosis
Synonyms cerebral cholesterinosis; cholestanol storage disease; CTx; sterol 27-hydroxylase deficiency; cerebrotendinous xanthomatosis
Definition
Cerebrotendinous xanthomatosis (CTX) is an anomaly of bile acid synthesis characterized by neonatal cholestasis, childhood-onset cataract, adolescent to young adult-onset tendon xanthomata, and brain xanthomata with adult-onset neurologic dysfunction.
Disease Hierarchy
DISUXA08: Inborn disorder of bile acid synthesis
DISSYRHC: Hereditary peripheral neuropathy
DISVY1TT: Leukodystrophy
DIS1L24B: Eye degenerative disorder
DIST11AK: Cholesterol catabolic process disease
DISPGGVL: Syndromic dyslipidemia
DISZF45C: Autosomal recessive metabolic cerebellar ataxia
DIS6KXVS: Xanthomatosis
DIS5HJ01: Subcutaneous tissue disorder
DISZSG9R: Cerebral lipidosis with dementia
DISPBCM3: Cerebellar degeneration
DIST9FNK: Cerebrotendinous xanthomatosis
Disease Identifiers
MONDO ID
MONDO_0008948
MESH ID
D019294
UMLS CUI
C0238052
OMIM ID
213700
MedGen ID
116041
Orphanet ID
909
SNOMED CT ID
63246000

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 1 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
SLC10A1 TTWZRY5 moderate Altered Expression [1]
------------------------------------------------------------------------------------
This Disease Is Related to 1 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
CYP27A1 DEBS639 Definitive Autosomal recessive [2]
------------------------------------------------------------------------------------
This Disease Is Related to 6 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
B4GALNT2 OT85V4QV moderate Altered Expression [3]
INSL6 OTF8OJQC moderate Biomarker [4]
POU2F2 OTPV0J0C moderate Biomarker [5]
SSPN OTYG2SL7 moderate Biomarker [3]
SPG11 OTZ7LJX4 Strong Genetic Variation [6]
CYP27A1 OT649C01 Definitive Autosomal recessive [2]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 DOT(s)

References

1 Disrupted coordinate regulation of farnesoid X receptor target genes in a patient with cerebrotendinous xanthomatosis.J Lipid Res. 2005 Feb;46(2):287-96. doi: 10.1194/jlr.M400256-JLR200. Epub 2004 Dec 1.
2 Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6.
3 Sarcospan-dependent Akt activation is required for utrophin expression and muscle regeneration.J Cell Biol. 2012 Jun 25;197(7):1009-27. doi: 10.1083/jcb.201110032.
4 Insulin-like 6 is induced by muscle injury and functions as a regenerative factor.J Biol Chem. 2010 Nov 12;285(46):36060-9. doi: 10.1074/jbc.M110.160879. Epub 2010 Aug 31.
5 Cerebrotendinous xanthomatosis patients with and without parkinsonism: clinical characteristics and neuroimaging findings.Mov Disord. 2010 Mar 15;25(4):452-8. doi: 10.1002/mds.22979.
6 Are Cognitive Changes in Hereditary Spastic Paraplegias Restricted to Complicated Forms?.Front Neurol. 2019 May 24;10:508. doi: 10.3389/fneur.2019.00508. eCollection 2019.